Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuwang Huang

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|November 6, 2010
Anti-proliferation and anti-angiogenesis of curcumin-K30 solid dispersionChun Chen, Xiuwang Huang, Huajing Cai, et al.
Drug Development and Industrial Pharmacy|August 27, 2010
Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailabilityXuemei Wu, Jianhua Xu, Xiuwang Huang, et al.
Drug Delivery|June 30, 2020
Enhanced anti-hepatoma effect of a novel curcumin analog C086 <i>via</i> solid dispersion technologyYanping Deng, Chun Chen, Zhifeng Xiao, et al.
ACS Omega|July 24, 2023
Synthesis of Novel Dual Target Inhibitors of CDK12 and PARP1 and Their Antitumor Activities in HER2-Positive Breast CancersShanshan Lin, Qingna Jiang, Xiuwang Huang, et al.
European Journal of Pharmacology|February 9, 2016
Curcumin analog L3 alleviates diabetic atherosclerosis by multiple effectsBin Zheng, Liu Yang, Caixia Wen, et al.
Bioorganic & Medicinal Chemistry|April 8, 2022
Synthesis of novel dual target inhibitors of PARP and EGFR and their antitumor activities in triple negative breast cancersShanshan Lin, Xiao Zhang, Zelei Yu, et al.
Bioorganic & Medicinal Chemistry|March 31, 2020
Synthesis of novel dual target inhibitors of PARP and HSP90 and their antitumor activitiesShanshan Lin, LingYu Zhang, Xiao Zhang, et al.
Cancer Chemotherapy and Pharmacology|April 17, 2007
Trichosanthin down-regulated p210Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562Kunzhong Zhang, Jianhua Xu, Xiuwang Huang, et al.
European Journal of Medicinal Chemistry|August 24, 2023
Discovery of X10g as a selective PROTAC degrader of Hsp90α protein for treating breast cancerQingna Jiang, Minghai Fu, Yuanling Tang, et al.
Frontiers in Pharmacology|May 16, 2022
Tissue Distribution, Excretion, and Interaction With Human Serum Albumin of Total Bioflavonoid Extract From <i>Selaginella doederleinii</i>Bing Chen, Dafen Xu, Zhijun Li, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|November 6, 2010
Anti-proliferation and anti-angiogenesis of curcumin-K30 solid dispersionChun Chen, Xiuwang Huang, Huajing Cai, et al.
Drug Development and Industrial Pharmacy|August 27, 2010
Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailabilityXuemei Wu, Jianhua Xu, Xiuwang Huang, et al.
Drug Delivery|June 30, 2020
Enhanced anti-hepatoma effect of a novel curcumin analog C086 <i>via</i> solid dispersion technologyYanping Deng, Chun Chen, Zhifeng Xiao, et al.
ACS Omega|July 24, 2023
Synthesis of Novel Dual Target Inhibitors of CDK12 and PARP1 and Their Antitumor Activities in HER2-Positive Breast CancersShanshan Lin, Qingna Jiang, Xiuwang Huang, et al.
European Journal of Pharmacology|February 9, 2016
Curcumin analog L3 alleviates diabetic atherosclerosis by multiple effectsBin Zheng, Liu Yang, Caixia Wen, et al.
Bioorganic & Medicinal Chemistry|April 8, 2022
Synthesis of novel dual target inhibitors of PARP and EGFR and their antitumor activities in triple negative breast cancersShanshan Lin, Xiao Zhang, Zelei Yu, et al.
Bioorganic & Medicinal Chemistry|March 31, 2020
Synthesis of novel dual target inhibitors of PARP and HSP90 and their antitumor activitiesShanshan Lin, LingYu Zhang, Xiao Zhang, et al.
Cancer Chemotherapy and Pharmacology|April 17, 2007
Trichosanthin down-regulated p210Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562Kunzhong Zhang, Jianhua Xu, Xiuwang Huang, et al.
European Journal of Medicinal Chemistry|August 24, 2023
Discovery of X10g as a selective PROTAC degrader of Hsp90α protein for treating breast cancerQingna Jiang, Minghai Fu, Yuanling Tang, et al.
Frontiers in Pharmacology|May 16, 2022
Tissue Distribution, Excretion, and Interaction With Human Serum Albumin of Total Bioflavonoid Extract From <i>Selaginella doederleinii</i>Bing Chen, Dafen Xu, Zhijun Li, et al.
Pageof 2